RK

Rajitha Kasthuri

Active Director Director DIN 10292134
DIN 10292134 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Rajitha Kasthuri

Data last updated:

Rajitha Kasthuri is a Director at Cosme Nova Pharma Private Limited (since 2023). Cosme Nova Pharma Private Limited reported revenue of ₹17.1 Lakh (FY 2025).

DIN 10292134
Primary Designation Director
First Appointment 24 Aug 2023
Oldest Company Age 3 yrs
Largest company Cosme Nova Pharma Private Limited · ₹17.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cosme Nova Pharma Private Limited U46497TS2023PTC176425
Director24 Aug 20232023₹17.1 Lakh (FY 2025)Active

Board colleagues of Rajitha Kasthuri

NameDINCompanyDesignation
Kasthuri Rayasammaiah10292135Cosme Nova Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cosme Nova Pharma Private Limited
Premium access

Shareholding and investment profile for Rajitha Kasthuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajitha Kasthuri

Rajitha Kasthuri currently holds 1 directorship: Cosme Nova Pharma Private Limited (Director, since 24 Aug 2023, revenue ₹17.1 Lakh (FY 2025)).

Rajitha Kasthuri was first appointed on 24 Aug 2023 as Director at Cosme Nova Pharma Private Limited.

The current boards of Rajitha Kasthuri's companies include Kasthuri Rayasammaiah (Cosme Nova Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available